Insulet (PODD) Competitors

Insulet (NASDAQ:PODD) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, community ranking, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Which has better earnings and valuation, PODD or BDX?

Becton, Dickinson and Company has higher revenue and earnings than Insulet. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.20B	10.39	$206.30M	$5.56	58.36
Becton, Dickinson and Company	$20.87B	2.38	$1.71B	$5.24	33.06

Does the media refer more to PODD or BDX?

In the previous week, Becton, Dickinson and Company had 12 more articles in the media than Insulet. MarketBeat recorded 36 mentions for Becton, Dickinson and Company and 24 mentions for Insulet. Becton, Dickinson and Company's average media sentiment score of 1.43 beat Insulet's score of 1.13 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	18 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	29 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is PODD or BDX more profitable?

Insulet has a net margin of 20.19% compared to Becton, Dickinson and Company's net margin of 8.47%. Insulet's return on equity of 24.46% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	20.19%	24.46%	8.33%
Becton, Dickinson and Company	8.47%	15.74%	7.29%

Does the MarketBeat Community prefer PODD or BDX?

Insulet received 132 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 66.31% of users gave Insulet an outperform vote while only 62.09% of users gave Becton, Dickinson and Company an outperform vote.

Company	Underperform	Outperform
Insulet	Outperform Votes 738 66.31%	Underperform Votes 375 33.69%
Becton, Dickinson and Company	Outperform Votes 606 62.09%	Underperform Votes 370 37.91%

Do insiders and institutionals hold more shares of PODD or BDX?

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.4% of Insulet shares are owned by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more volatility and risk, PODD or BDX?

Insulet has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500.

Do analysts rate PODD or BDX?

Insulet presently has a consensus price target of $306.53, suggesting a potential downside of 5.54%. Becton, Dickinson and Company has a consensus price target of $231.44, suggesting a potential upside of 33.59%. Given Becton, Dickinson and Company's higher possible upside, analysts clearly believe Becton, Dickinson and Company is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Becton, Dickinson and Company	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45

Summary

Insulet beats Becton, Dickinson and Company on 12 of the 18 factors compared between the two stocks.